146 related articles for article (PubMed ID: 9399978)
1. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.
Zhang Y; Shaffer A; Portanova J; Seibert K; Isakson PC
J Pharmacol Exp Ther; 1997 Dec; 283(3):1069-75. PubMed ID: 9399978
[TBL] [Abstract][Full Text] [Related]
2. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats.
Dirig DM; Isakson PC; Yaksh TL
J Pharmacol Exp Ther; 1998 Jun; 285(3):1031-8. PubMed ID: 9618405
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.
Anderson GD; Hauser SD; McGarity KL; Bremer ME; Isakson PC; Gregory SA
J Clin Invest; 1996 Jun; 97(11):2672-9. PubMed ID: 8647962
[TBL] [Abstract][Full Text] [Related]
5. The effect of a peripheral block on inflammation-induced prostaglandin E2 and cyclooxygenase expression in rats.
Beloeil H; Gentili M; Benhamou D; Mazoit JX
Anesth Analg; 2009 Sep; 109(3):943-50. PubMed ID: 19690271
[TBL] [Abstract][Full Text] [Related]
6. Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs.
Bianchi M; Martucci C; Ferrario P; Franchi S; Sacerdote P
Anesth Analg; 2007 Apr; 104(4):949-54. PubMed ID: 17377112
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory effects of 2 Hz electroacupuncture with different intensities on acute carrageenan-induced inflammation in the rat paw.
Lee JH; Choi YH; Choi BT
Int J Mol Med; 2005 Jul; 16(1):99-102. PubMed ID: 15942684
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat.
Jett MF; Ramesha CS; Brown CD; Chiu S; Emmett C; Voronin T; Sun T; O'Yang C; Hunter JC; Eglen RM; Johnson RM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1288-97. PubMed ID: 10027870
[TBL] [Abstract][Full Text] [Related]
9. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
Futaki N; Harada M; Sugimoto M; Hashimoto Y; Honma Y; Arai I; Nakaike S; Hoshi K
J Pharm Pharmacol; 2009 May; 61(5):607-14. PubMed ID: 19405999
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity.
Ndengele MM; Cuzzocrea S; Esposito E; Mazzon E; Di Paola R; Matuschak GM; Salvemini D
FASEB J; 2008 Sep; 22(9):3154-64. PubMed ID: 18497304
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.
Chan CC; Boyce S; Brideau C; Ford-Hutchinson AW; Gordon R; Guay D; Hill RG; Li CS; Mancini J; Penneton M
J Pharmacol Exp Ther; 1995 Sep; 274(3):1531-7. PubMed ID: 7562530
[TBL] [Abstract][Full Text] [Related]
12. The effects of intrathecal cyclooxygenase-1, cyclooxygenase-2, or nonselective inhibitors on pain behavior and spinal Fos-like immunoreactivity.
Lee IO; Seo Y
Anesth Analg; 2008 Mar; 106(3):972-7, table of contents. PubMed ID: 18292448
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor.
Padi SS; Jain NK; Singh S; Kulkarni SK
Eur J Pharmacol; 2004 Apr; 491(1):69-76. PubMed ID: 15102535
[TBL] [Abstract][Full Text] [Related]
15. ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
Harris RR; Black L; Surapaneni S; Kolasa T; Majest S; Namovic MT; Grayson G; Komater V; Wilcox D; King L; Marsh K; Jarvis MF; Nuss M; Nellans H; Pruesser L; Reinhart GA; Cox B; Jacobson P; Stewart A; Coghlan M; Carter G; Bell RL
J Pharmacol Exp Ther; 2004 Dec; 311(3):904-12. PubMed ID: 15277581
[TBL] [Abstract][Full Text] [Related]
16. Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan.
França DS; Ferreira-Alves DL; Duarte ID; Ribeiro MC; Rezende RM; Bakhle YS; Francischi JN
Neuropharmacology; 2006 Jul; 51(1):37-43. PubMed ID: 16620880
[TBL] [Abstract][Full Text] [Related]
17. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
18. Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats.
Ahn DK; Chae JM; Choi HS; Kyung HM; Kwon OW; Park HS; Youn DH; Bae YC
Pain; 2005 Sep; 117(1-2):204-13. PubMed ID: 16098663
[TBL] [Abstract][Full Text] [Related]
19. Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors.
Huntjens DR; Spalding DJ; Danhof M; Della Pasqua OE
Eur J Pain; 2009 May; 13(5):448-57. PubMed ID: 18774319
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
